Optogenetic Market Research Report- Global Forecast To 2027

Optogenetic Market by product type (light instruments, actuators, sensors), by application (retinal diseases treatment, hearing problems treatment, neuroscience, and others), - Forecast to 2027

ID: MRFR/LS/0799-HCR | February 2021 | Region: Global | 80 pages

Optogenetics Market Overview


The optogenetics market size is likely to enhance at 17% during the ongoing forecast period of 2017-2023. Optogenetics refers to a new kind of technology and research method that has resulted in revolutionizing neuroscience in recent years. The growth of the optogenetics market operations is inclusive of the scope of the undertaken developments. Optogenetics is gaining a lot of recognition in the form of a potential diagnosis tool that applies to the field of neurosciences and is backed by the rapid advancement in the field of advancing technology and a steep increase in the use of multimodal imaging.


Optogenetics is a new research method that has been developed to transform neuroscience and is gearing up for giving rise to new possibilities that will help in enhancing the understanding levels of how a human brain functions.


COVID 19 Analysis


It is an undeniable fact that since the arrival of the pandemic, the global economies are functioning at a much slower pace. The businesses have experienced various losses during the period and most of the people are out of jobs. There has been a huge challenge for the global audience that their lifestyle is at stake with a huge need for the audience to bend to the optogenetics market upheaval and opt for relative changes. However, the businesses related to the medical field, and pharmaceutical companies are taking a front seat to combat the transmission rate of the pandemic but combining the treatment practices with innovation that will help the world and the global markets to overcome the effects of the pandemic.


With the medical professionals and pharmaceutical companies lending such incredible services, they aspire for positive growth by the end of the forecast period in 2023. There is a new burst of innovation and creativity in the market in the infectious landscape to compete with the race for treating people who have contracted the disease. Also, the rising investment from the government and public sector is likely to ring in positive attributes for the optogenetics market to grow as per the predicted industry leaders and market players for the forecast period of 2017-2023. 


Optogenetics Market Dynamics


Drivers


The field of optogenetics is pushed to the rise of a new era that has potent and targeted control over a huge number of aspects of neural functioning. Both the optical methods and genetics, when applied together allow to have a tight spatial and temporal control of the various activities of different kinds that are conducted by the neurons, as part of the brain. This field is being understood as a revolutionary advancement and will help in achieving an excellent level of understanding and further, helping in providing a millisecond-scale temporal precision that allows the experimenter. This helps in keeping pace with the process related to extracting fast biological information.


Restraints


The optogenetics applications in small animals are yielding new insights in the fields of basic neuroscience and diseases of the nervous systems. These have utmost importance as they can translate the newest technological for nonhuman primates and human tissues. However, the emergence of severe issues gives rise to concerns related to the importance of safety when it comes to the smaller size of tolerance and differing susceptibility ratio to the infectious vectors. This might give rise to various kinds of restraints that might bar the optogenetics market operations from expanding as per the predictions during the forecast period that ends in 2023.


Technology Analysis


Depression is one of the most common mental diseases that pose a threat to life. The study on depression was carried out for a long period that shows that fundamental mechanics in most of the cases stands unrevealed. The efficiency rate for antidepressants is just 28%. Also, it has been noticed that approximately 30-40% of people who are suffering from depression are resistant to medication or any other kind of treatment. The development in the methods related to documentation and managing neural activity in the reward system, as a part of the brain has helped in having a better clarity and providing similar treatments that will result in improving the condition of the patients.


FIGURE:  GLOBAL OPTOGENETIC MARKET SHARE BY PRODUCT TYPE, 2016 (%)


Optogenetics Market Segment Overview


To understand the revenue potential of the market, it is important to have an understanding of the working of the market segments. The market has been segmented based on the following:


Based on the sensor type:


The optogenetics market includes calcium sensors, chloride sensors like a chameleon, membrane-grated like a mermaid, and other sensors.


Based on application:


The application segment of the market includes retinal disease treatment, behavioral tracking, neuroscience, and other applications.


Based on optogenetics market end-users:


The market end-users are distributed amongst psychiatrists, hospitals, care centers, clinics, diagnostic centers, research institutes, and others.


Based on the region:


The global regions have been divided into 5 major regions that are North America, the European nations, the APAC region, Latin America, and the Middle East and Africa.


Regional Analysis


Based on the optogenetics market; trends, the North American region is expected to hold the largest market share, and thus, dominate the global market operations. One of the major reasons that are driving the growth in this region is the increased use of optogenetic devices in academies and research laboratories. As per the Parkinson’s Foundation, there are approximately 1.2 million people as a part of the US population that is estimated to suffer from the disease by the end of 2030.


Optogenetics Market Competitive Landscape


Based on the rising demand and supply pattern of the optogenetics industry, a higher degree of prevailing competition is expected during the forecast period that ends in 2023. Also, the rising competitive degree helps in enhancing the level of developments that are being undertaken by the market players during the period. To help the market investors and buyers have a better hand at the market insights, the report discusses the following prominent optogenetics market players:



  • Shanghai Laser & Optics Century Co. Ltd. (SLOC)

  • GenSight Biologics

  • Addgene

  • THE JACKSON LABORATORY

  • Danaher

  • Prizmatix

  • Cohorent

  • Thorlabs, Inc

  • Bruker

  • Circuit Therapeutics, Inc

  • Noldus Information Technology

  • Judges Scientific plc

  • Scientific

  • Merck KGaA, agtc

  • Elliot Scientific Limited


Recent Developments



  • The US federal budget estimated a sum of USD 100 million for the BRAIN initiative that is increasing its funding by a sum of USD 100 million with each passing year, since the historic year of 2014. These factors will help in a huge rise of the market operations in the US market of the North American region.

  • RetroSense Therapeutics completed the low-dose cohort as a part of the clinical trial carried out of the gene therapy application that is related to the field of optogenetics.

  • The LED market segment is included to have the largest optogenetics market share during the forecast period that ends in 2023 is because they are cheaper, easier degree of control and measurement, offer better convenience, and better reliability as consumer products. These market products are being incorporated into implants that allow an untethered delivery of light, thus, enhancing the consumer experience and thus, increase sales.


Optogenetics Market Report Overview


The optogenetics market report highlights the important recent developments of the market players that will impact the growth rate and the final market value by the end of the forecast period in 2023. The report helps in identifying important market factors like the drivers and opportunities that will stimulate the market growth as per the predictions and the possible factors that might restrain the market from growing. The report covers the role of the market segments and highlights their ability to meet the needs of the target audience during the forecast period.


Study Objectives



  • To have a deep idea about the distribution of the market resources, raw material, and investment that will help the industry leaders and market experts understand the working and potential of the market segments that are functional in various global regions. And further, see the potential of these segments to meet the demands of the target audience and earn the expected revenues in the forecast period.

  • To study the change accelerated by the arrival of the pandemic in 2020 in terms of the preferences of the customers and the trend that prevails amongst the global target audience in the current scenario which is likely to have an impact on the demand formulated for the market services.

  • To have an idea about the fresh market trends that are a part of the technological advancements on the way for the betterment and enhancement of the global market operations and recent developments that have been undertaken by the optogenetics market players giving rise to a great degree of competition during the forecast period that ends in 2023.



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 50 Million
  CAGR   17% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   product type and application
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Coherent Inc., Thorlabs Inc., Scientifica, Laserglow technologies, Regenxbio Inc., Addgene, UPenn Vector Core and Jackson Laboratories., Cobalt International Energy
  Key Market Opportunities   Advancement in the technology and research
  Key Market Drivers   Joint ventures, strategic alliances, mergers and acquisitions, new product developments


Frequently Asked Questions (FAQ) :


Optogenetic market is projected to grow at approximately 17% CAGR during the assessment period (2017-2023).

Optogenetic market is estimated to reach a valuation of approx. USD 50 MN by the end of 2023.

Increasing uses in the field of neuroscience and behavioural science and rapid advancement in technology such as ultrafast laser tools, are major tailwinds pushing the growth of the global Optogenetic market.

North America holds the largest share in the global Optogenetic market, followed by Europe and the Asia Pacific, respectively.

Coherent Inc. (U.S.), Laserglow technologies (Canada), Thorlabs Inc. (U.S.), Regenxbio Inc. (U.S.), UPenn Vector Core (U.S.), Addgene (U.S.), Jackson Laboratories. (U.S.), and Cobalt International Energy, Inc. (U.S.), are some of the top players operating in the global Optogenetic market.

1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3 MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4 MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

5 GLOBAL OPTOGENETICMARKET, BY PRODUCT TYPE

5.1 LIGHT INSTRUMENTS

5.1.1 LEDs

5.1.2 LASERS

5.2 ACTUATORS

5.2.1 CHANNELRHODOSPIN

5.2.2 HALORHODOSPIN

5.2.3 ARCHAERHODOSPIN

5.3 SENSORS

5.3.1 CALCIUM SENSORS AWQUORIN

5.3.2 CAMELEON

5.3.3 GCaMP

5.3.4 CHLORIDE

5.3.5 MEMBRANE GATED

6. GLOBAL OPTOGENETICMARKET, BY APPLICATION

6.1 NEUROSCIENCE

6.2 RETINAL DISEASES TREATMENT

6.3 HEARING PROBLEM TREATMENT

6.4 BEHAVIORAL TRACKING

6.5 CARDIOVASCULAR ALIGNMENT

6.6 PACING

7. GLOBAL OPTOGENETICMARKET, BY REGION

7.1 INTRODUCTION

7..2 AMERICAS

7.2.1 NORTH AMERICA

7.2.1.2 U.S

7.2.1.2 CANADA

7.2.1.3 SOUTH AMERICA

7.3 EUROPE

7.3.1 GERMANY

7.3.2 FRANCE

7.3.3 ITALY

7.3.4 SPAIN

7.3.5 U.K

7.3.6 REST OF EUROPE

7.4. ASIA-PACIFIC

7.4.1 JAPAN

7.4.2 CHINA

7.4.3 INDIA

7.4.4 REPUBLIC OF KOREA

7.5 MIDDLE EAST & AFRICA

7.5.1 UAE

7.5.2 SAUDI AERBIA

7.5.3 KUWAIT

7.5.4 QATAR

7.5.5 OMAN

8. COMPETITIVE LANDSCAPE

8.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS

8.1.1 STRATEGIC PARTNERSHIP

8.1.2 MERGER & ACQUISITION

9 COMPANY PROFILE

9.1 ADDGENE

9.1.1 OVERVIEW

9.1.2 PRODUCT OVERVIEW

9.1.3 FINANCIALS

9.1.4 KEY DEVELOPMENTS

9.2 COBALT INTERNATIONAL ENERGY INC.

9.2.1 OVERVIEW

9.2.2 PRODUCT OVERVIEW

9.2.3 FINANCIALS

9.2.4 KEY DEVELOPMENTS

9.3 COHERENT

9.3.1 OVERVIEW

9.3.2 PRODUCT OVERVIEW

9.3.3 FINANCIALS

9.3.4 KEY DEVELOPMENT

9.4 LASER GLOW TECHNOLOGY

9.4.1 OVERVIEW

9.4.2 PRODUCT OVERVIEW

9.4.3 FINANCIALS

9.4.4 KEY DEVELOPMENTS

9.5 JACKSON LABORATORIES

9.5.1 OVERVIEW

9.5.2 PRODUCT OVERVIEW

9.5.3 FINANCIALS

9.5.4 KEY DEVELOPMENTS

9.6 REGENXBIO INC.

9.6.1 OVERVIEW

9.6.2 PRODUCT OVERVIEW

9.6.3 FINANCIALS

9.6.4 KEY DEVELOPMENTS

9.7 THORLABS

9.7.1 OVERVIEW

9.7.2 PRODUCT OVERVIEW

9.7.3 FINANCIALS

9.7.4 KEY DEVELOPMENTS

9.9 OTHERS